LOS ANGELES--(BUSINESS WIRE)---- $LIFE #CapitalCommitment--Russian listed pharmaceutical manufacturer, Pharmsynthez PJSC (MOEX:LIFE), secures 800 million rubles from global alternative investor, LDA C
Event will feature Dr. Daniel Culver, Director of the Interstitial Lung Disease Program at the Cleveland Clinic.
Preclinical candidate is second to demonstrate selective blocking ability from in-house panel of antibodies targeting NRP2.
Genscript raised more than $1 billion from Hillhouse Capital in several different investments, including a $500 million commitment to Genscript's Legend Biotech CAR-T subsidiary. Shanghai Fosun Pharma
aTyr Pharma, Inc. (LIFE) CEO Sanjay Shukla on Q1 2021 Results - Earnings Call Transcript
Atyr Pharma (LIFE) delivered earnings and revenue surprises of -50.00% and -100.00%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Atyr Pharma (LIFE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Panel discussion on steroids and sarcoidosis to be held on Tuesday, April 27 at 12:00pm ET / 3:00pm PT Panel discussion on steroids and sarcoidosis to be held on Tuesday, April 27 at 12:00pm ET / 3:00
Findings demonstrate tumor inhibitory effects of ATYR2810 when used as a monotherapy or in combination with chemotherapy in models of non-small cell lung cancer.
aTyr Pharma, Inc. (LIFE) CEO Dr. Sanjay Shukla on Q4 2020 Results - Earnings Call Transcript

aTyr Pharma: Q4 Earnings Insights

04:46pm, Tuesday, 23'rd Mar 2021
Shares of aTyr Pharma (NASDAQ:LIFE) rose in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 69.48% over the past year to ($0.47), which beat the
Completed enrollment of ATYR1923 clinical trial in patients with pulmonary sarcoidosis. Data is expected in the third quarter.
Atyr Pharma (LIFE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Atyr Pharma (LIFE) stock is taking off on Tuesday after getting a price target update from Roth Capital analyst Zegbeh Jallah. The post LIFE Stock: Increased Price Target Gives aTyr Pharma Shares a Bi
These seven names have shown important insider trading signals after their rallies, meaning some insiders are taking profits in these stocks. The post 7 Stocks With Important Insider Trading Signals T
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE